COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites - PubMed (original) (raw)
Review
COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites
Maria Burian et al. Pharmacol Ther. 2005 Aug.
Abstract
Despite the diverse chemical structure of aspirin-like drugs, the antinociceptive effect of NSAIDs is mainly due to their common property of inhibiting cyclooxygenases involved in the formation of prostaglandins. Prostaglandins are potent hyperalgesic mediators which modulate multiple sites along the nociceptive pathway and enhance both transduction (peripheral sensitizing effect) and transmission (central sensitizing effect) of nociceptive information. Inhibition of the formation of prostaglandins at peripheral and central sites by NSAIDs thus leads to the normalisation of the increased pain threshold associated with inflammation. The contribution of peripheral and central mechanisms to the overall antinociceptive action of NSAIDs depends on several factors including the location of the targets of drug action, the site of drug delivery and the uptake and distribution to the site of action. The present work reviews the data on the regulation and location of cyclooxygenases at central and peripheral sites of the nociceptive pathway and focuses on the role of COX in the generation and maintenance of pain hypersensitivity. Experimental and clinical evidences are used to evaluate the significance of the peripheral and central antihyperalgesic effects of NSAIDs.
Similar articles
- Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.
Kashfi K, Rigas B. Kashfi K, et al. Biochem Pharmacol. 2005 Oct 1;70(7):969-86. doi: 10.1016/j.bcp.2005.05.004. Biochem Pharmacol. 2005. PMID: 15949789 Review. - Inhibitors of cyclooxygenases: mechanisms, selectivity and uses.
Botting RM. Botting RM. J Physiol Pharmacol. 2006 Nov;57 Suppl 5:113-24. J Physiol Pharmacol. 2006. PMID: 17218763 Review. - [Antinociceptive mechanism of action of paracetamol].
Bonnefont J, Courade JP, Alloui A, Eschalier A. Bonnefont J, et al. Drugs. 2003;63 Spec No 2:1-4. Drugs. 2003. PMID: 14758785 Review. French. - Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process.
Vuolteenaho K, Moilanen T, Moilanen E. Vuolteenaho K, et al. Basic Clin Pharmacol Toxicol. 2008 Jan;102(1):10-4. doi: 10.1111/j.1742-7843.2007.00149.x. Epub 2007 Oct 31. Basic Clin Pharmacol Toxicol. 2008. PMID: 17973900 Review.
Cited by
- Semi-mechanistic modeling of the interaction between the central and peripheral effects in the antinociceptive response to lumiracoxib in rats.
Vélez de Mendizábal N, Vásquez-Bahena D, Jiménez-Andrade JM, Ortiz MI, Castañeda-Hernández G, Trocóniz IF. Vélez de Mendizábal N, et al. AAPS J. 2012 Dec;14(4):904-14. doi: 10.1208/s12248-012-9405-y. Epub 2012 Sep 12. AAPS J. 2012. PMID: 22968496 Free PMC article. - Does non-steroidal anti-inflammatory drugs-related preemptive analgesia modulate SOCS3/IL-6 pathway in oral surgery?
Albuquerque AFM, do Nascimento Costa JJ, Silva JRV, Silva PGB, Chaves FN, Maferano EFE, Filho ELC, Pereira KMA, Santiago SL, Ribeiro TR, Costa FWG. Albuquerque AFM, et al. Inflammopharmacology. 2024 Apr;32(2):1017-1024. doi: 10.1007/s10787-024-01433-y. Epub 2024 Feb 12. Inflammopharmacology. 2024. PMID: 38347301 No abstract available. - Rocuronium-induced withdrawal movement: influence of ketorolac or a combination of lidocaine and ketorolac pretreatment.
Jeon Y, Ha JH, Lee JE, Lee HC, Ryu T, Kwak KH. Jeon Y, et al. Korean J Anesthesiol. 2013 Jan;64(1):25-8. doi: 10.4097/kjae.2013.64.1.25. Epub 2013 Jan 21. Korean J Anesthesiol. 2013. PMID: 23372882 Free PMC article. - Brazilian medicinal plants with corroborated anti-inflammatory activities: a review.
Ribeiro VP, Arruda C, Abd El-Salam M, Bastos JK. Ribeiro VP, et al. Pharm Biol. 2018 Dec;56(1):253-268. doi: 10.1080/13880209.2018.1454480. Pharm Biol. 2018. PMID: 29648503 Free PMC article. Review. - The neurologic pain signature responds to nonsteroidal anti-inflammatory treatment vs placebo in knee osteoarthritis.
López-Solà M, Pujol J, Monfort J, Deus J, Blanco-Hinojo L, Harrison BJ, Wager TD. López-Solà M, et al. Pain Rep. 2022 Feb 16;7(2):e986. doi: 10.1097/PR9.0000000000000986. eCollection 2022 Mar-Apr. Pain Rep. 2022. PMID: 35187380 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials